SCHEMBL16401682

SCHEMBL16401682

NS(=O)(=O)c1cccc(C2CCCCN2C(=O)O)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 1/20 0.49
CFB P00751 1/20 0.47
CPT2 P23786 1/20 0.45
CPT1A P50416 1/20 0.45
CA2 P00918 4/20 0.44
CA12 O43570 3/20 0.44
CA1 P00915 3/20 0.44
CA9 Q16790 3/20 0.44
CA7 P43166 2/20 0.44
CA14 Q9ULX7 2/20 0.44
PARP14 Q460N5 2/20 0.43
PARP10 Q53GL7 1/20 0.43
NR1H2 P55055 4/20 0.43
NR1H3 Q13133 4/20 0.43
RIPK1 Q13546 2/20 0.43
HSP90AA1 P07900 1/20 0.43
HSP90AB1 P08238 1/20 0.43
HSD11B1 P28845 1/20 0.41
TMEM97 Q5BJF2 1/20 0.40
SIGMAR1 Q99720 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16401485 0.84 CA2 (0.54) CFBCPT1ACA2CA12CA1
SCHEMBL17782219 0.83 NR1H2 (0.51) ROCK2CFBCPT2CPT1ACA2
SCHEMBL17513435 0.83 ROCK2 (0.53) ROCK2NR1H2NR1H3RIPK1SIGMAR1
SCHEMBL28097481 0.80 HSP90AA1 (0.53) ROCK2PARP14PARP10RIPK1HSP90AA1
SCHEMBL16401372 0.79 TMEM97 (0.48) ROCK2CFBCPT2CPT1ACA2
SCHEMBL216202 0.79 RIPK1 (0.62) PARP14PARP10RIPK1HSP90AA1HSP90AB1
SCHEMBL27574934 0.79 RIPK1 (0.62) PARP14PARP10RIPK1HSP90AA1HSP90AB1
SCHEMBL27574946 0.79 RIPK1 (0.62) PARP14PARP10RIPK1HSP90AA1HSP90AB1
SCHEMBL25319552 0.79 SCD5 (0.47) ROCK2PARP14PARP10RIPK1HSP90AA1
SCHEMBL6246105 0.79 RIPK1 (0.66) PARP14PARP10RIPK1HSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3022192-A1 PIPERIDINYL INDOLE DERIVATIVES AND THEIR USE AS COMPLEMENT FACTOR B INHIBITORS Novartis AG (CH) 2016-05-25 EP disclosed
WO-2015009616-A1 PIPERIDINYL INDOLE DERIVATIVES AND THEIR USE AS COMPLEMENT FACTOR B INHIBITORS NOVARTIS AG (CH) 2015-01-22 WO disclosed